Canadian marijuana titan Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB) together with 22nd Century Group, Inc. (NASDAQ:XXII) will license biosynthesis intellectual property to Cronos Group Inc.

EDMONTON, AB, Dec. 14, 2021 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) ("Aurora"), the Canadian company defining the future of cannabinoids ...

Add Yahoo as a preferred source to see more of our stories on Google. We understand that this is a decision that was mutually made by both the studio and Cinemark which owned the Century 16, now known ...

Biosynthesis is a process common in the pharmaceutical industry, which involves using living micro-organisms to convert simple substances into complex compounds. Through biosynthesis, cannabinoids - ...